Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05362357 · ClinicalTrials.gov registry record · NA
iSTART: A Campus & Community Initiative for Services in Tec-health
A NA study, sponsored by California State University, Northridge.
- Completed
- Registry status
- NA
- Development phase
- 1,100
- Enrollment target
NCT05362357: Completed NA study, sponsored by California State University, Northridge.
NCT05362357 is a NA study that has completed, run by California State University, Northridge. The registered enrollment target is 1,100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (22% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05362357, a NA study, has completed, sponsored by California State University, Northridge.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,100 participants
- Enrollment target
Study Summary
The iSTART intervention is a 30-day substance prevention web-app whereby students complete five weekly interactive modules using a smart device or computer. Each module is approximately 15 minutes long, and focuses on a select substance: (i) alcohol, (ii) marijuana, (iii) nicotine, (iv) prescription drugs, and (v) illicit drugs. The modules are based on key theoretical constructs, behavior change strategies, and practical module components: attitudes (knowledge), perceived susceptibility (risk perceptions), subjective norms (normative re-education), and self-efficacy (refusal skills). This intervention will be evaluated via a time series design using a sample of 600 students randomly assigned to either the intervention, comparison, or control condition at a public institution in southern California.
Primary Outcome
Measured as the number of days drinking alcohol in past 30-days
Interventions
- BEHAVIORAL iSTART Web-app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,100 participants |
| Start Date | 2021-02-20 |
| Est. Completion | 2023-12-04 |
| Phase | NA |
What the finished NCT05362357 record still lists
NCT05362357 is an interventional study that assigns participants to a tested intervention. Its 1,100 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (22% lower).
The record links to 0 conditions, and to 1 intervention - of which iSTART Web-app is the first listed.
NCT05362357 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05362357 about?
NCT05362357 is a clinical study titled "iSTART: A Campus & Community Initiative for Services in Tec-health". The iSTART intervention is a 30-day substance prevention web-app whereby students complete five weekly interactive modules using a smart device or computer. Each module is approximately 15 minutes long, and focuses on a select substance: (i) alcohol, (ii) marijuana, (iii) nicotine, (iv) prescription...
What is the current status of trial NCT05362357?
This trial is currently completed. It is a NA study. The enrollment target is 1,100 participants. The study started on 2021-02-20. Estimated completion is 2023-12-04.
What interventions are being tested in trial NCT05362357?
The interventions under investigation include: iSTART Web-app (BEHAVIORAL).
Who is sponsoring clinical trial NCT05362357?
This trial is sponsored by California State University, Northridge, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05362357's enrollment target sits among peer trials
1,100 93rd of 2000 higher than 1,906 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00710112 · 1,100 participants
Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
- NCT02688517 · 1,100 participants
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
- NCT04743765 · 1,100 participants · NA
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
- NCT05638581 · 1,100 participants · Phase 3
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI